Epstein-Barr virus Roche BK Virus Test Garners FDA Clearance The RT-PCR test runs on the Cobas 6800/8800 Systems and had previously received breakthrough device designation from the FDA. Roche Epstein-Barr Virus Quantitative Test Receives FDA Clearance The PCR viral load test runs on the Cobas 6800/8800 systems and has been calibrated to the World Health Organization International Standard, Roche said. Liquid Biopsy Effort Aims to Improve Diagnosis of Childhood Viral Lymphomas in Sub-Saharan Africa Premium A four-year, $5.5 million program will assess whether circulating cell-free DNA testing can improve diagnosis and outcomes for a type of EBV-associated cancer. Viral Cancer Early Detection Efforts Making Progress Toward the Clinic Premium Researchers are making improvements to viral-DNA detection methods and are exploring applications not just for screening but also disease monitoring. NeuMoDx Gets CE Mark for Cytomegalovirus, Epstein-Barr Virus Tests NeuMoDx's tests are designed for central laboratory use and run on the company's fully automated NeuMoDx 96 or 288 real-time PCR systems. Jun 17, 2019 Risky Epstein-Barr Virus Variants Found in South China Nasopharyngeal Cancer Cases May 9, 2019 Arc Bio Introduces Sample-to-Answer RUO NGS Kit for Transplant Viruses; Beta Users Report Data at CVS Premium Dec 21, 2018 Novacyt Gets CE Marks for BK, Epstein-Barr Tests May 15, 2018 Team Describes Early Detection Test for Nasopharyngeal Carcinoma; Grail to Commercialize This Year Premium Apr 16, 2018 Epstein-Barr Virus Protein, Human Transcription Factors Implicated in Autoimmune Diseases Jul 21, 2011 BioMérieux Buys Argene to Bolster Test Menu for Biocartis MDx Platform Premium Jul 19, 2011 BioMérieux Buys Argene for up to $60.1M Apr 28, 2011 Dx Focus Apr 28, 2011: Clinical and Regulatory PCR and Nucleic Acid Testing News Premium Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.